Robert Mullins

Prof. Robert Mullins

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2001 in Progress in Retinal and Eye Research
Verified
Journal Article
Closed access
GHG S Hageman
G S Hageman
PLP J Luthert
P J Luthert
Victor ChongVictor Chong
Victor Chong
LJL V Johnson
L V Johnson
DAD H Anderson
D H Anderson
RMRobert Mullins
Robert Mullins

1 September 2002 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
DADon H Anderson
Don H Anderson
RMRobert Mullins
Robert Mullins
GHGregory S Hageman
Gregory S Hageman
LJLincoln V Johnson
Lincoln V Johnson


25 April 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
ESElliott H Sohn
Elliott H Sohn
HDHille W. van Dijk
Hille W. van Dijk
CJChunhua Jiao
Chunhua Jiao
PKPauline H. B. Kok
Pauline H. B. Kok
WJWoojin Jeong
Woojin Jeong
MAMichael David Abràmoff
Michael David Abràmoff
Diabetic retinopathy (DR) has long been recognized as a microvasculopathy, but retinal diabetic neuropathy (RDN), characterized by inner retinal neurodegeneration, also occurs in people with diabetes mellitus (DM). We report that in 45 people with DM and no to minimal DR there was significant, progressive loss of the nerve fiber layer (NFL) (0.25 μm/y) and the ganglion cell (GC)/inner plexiform layer (0.29 μm/y) on optical coherence tomography analysis (OCT) over a 4-y period, independent of glycated hemoglobin, age, and sex. The NFL was significantly thinner (17.3 μm) in the eyes of six donors with DM than in the eyes of six similarly aged control donors (30.4 μm), although retinal capillary density did not differ in the two groups. We confirmed significant, progressive inner retinal thinning in streptozotocin-induced “type 1” and B6.BKS(D)-Leprdb/J “type 2” diabetic mouse models on OCT; immunohistochemistry in type 1 mice showed GC loss but no difference in pericyte density or acellular capillaries. The results suggest that RDN may precede the established clinical and morphometric vascular changes caused by DM and represent a paradigm shift in our understanding of ocular diabetic complications.

1 September 2017 in Ophthalmology
Verified
Journal Article
Closed access
ESEdwin M. Stone
Edwin M. Stone
JAJeaneen L. Andorf
Jeaneen L. Andorf
SWS. Scott Whitmore
S. Scott Whitmore
ADAdam P. DeLuca
Adam P. DeLuca
JGJoseph C. Giacalone
Joseph C. Giacalone
BTBudd Tucker
Budd Tucker

11 November 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
AVAndrew P Voigt
Andrew P Voigt
KMKelly Mulfaul
Kelly Mulfaul
NMNathaniel Mullin
Nathaniel Mullin
MFMiles J. Flamme-Wiese
Miles J. Flamme-Wiese
JGJoseph C. Giacalone
Joseph C. Giacalone
RMRobert Mullins
Robert Mullins
The human retinal pigment epithelium (RPE) and choroid are complex tissues that provide crucial support to the retina. Disease affecting either of these supportive tissues can lead to irreversible blindness in the setting of age-related macular degeneration. In this study, single-cell RNA sequencing was performed on macular and peripheral regions of RPE-choroid from 7 human donor eyes in 2 independent experiments. In the first experiment, total RPE/choroid preparations were evaluated and expression profiles specific to RPE and major choroidal cell populations were identified. As choroidal endothelial cells represent a minority of the total RPE/choroidal cell population but are strongly implicated in age-related macular degeneration (AMD) pathogenesis, a second single-cell RNA-sequencing experiment was performed using endothelial cells enriched by magnetic separation. In this second study, we identified gene expression signatures along the choroidal vascular tree, classifying the transcriptome of human choriocapillaris, arterial, and venous endothelial cells. We found that the choriocapillaris highly and specifically expresses the regulator of cell cycle gene ( RGCC ), a gene that responds to complement activation and induces apoptosis in endothelial cells. In addition, RGCC was the most up-regulated choriocapillaris gene in a donor diagnosed with AMD. These results provide a characterization of the human RPE and choriocapillaris transcriptome, offering potential insight into the mechanisms of choriocapillaris response to complement injury and choroidal vascular disease in age-related macular degeneration.